ECRFPlus
The Pioneers in Developing eClinical Technology

Over the years, the pharma industry has been widely adopting the EDC and the eClinical solution. But conventional eClinical solutions still require manual CRF data entry and manual process for SDV and data quality control, which significantly increase the cost of a study. That’s where ECRFPlus can help.

Established in the year 2006 and headquartered in China, ECRFPlus is the pioneer in developing eClinical technology for sponsors and sites. Its sponsor eClinical solution include e-CRF+® CTMS, EDC, IWRs, Supply, eTMF, and ECG/ ABPM, and its site eClinical solution offer products such as e-CRF+® GEI, sCTMS, sEDC, PIMS/BEIS, etc. The company is the advocate and leader in China in transforming the sites towards digital trials and has developed a close relationship with hundreds of clinical sites through providing site eClinical solutions. “We have established nationwide eClinical trials service network and partner with CROs and SMOs, offering one-stop shop for end-to-end Phase I-IV digital clinical trials services through 3Q XaaS platform,” says Ming Lu, the CEO and Chief Architect of ECRFPlus.

ECRFPlus 3Q framework makes sponsor eClinical solution seamlessly integrated with site eClinical solution possible, allowing sponsors and sites to share study process information and CRF data in a regulatory-compliant and secure environment. The company’s solution could automatically extract CRF data from the sources and avoid manual data entry and SDV. Also, AI can be applied for subject screening, data cleaning, quality control, and auditing. It is the only company that has developed such an advanced eClinical solution. In addition, its site eClinial solution has been adopted by many leading Chinese hospitals, and this makes it possible to conduct end-to-end multi-site digital clinical trials.

The first product that ECRFPlus provided is e-CRF+® xCTMS, which is the next generation of clinical trial management solution. It is designed based on the latest digital transformation of healthcare systems at sites, allowing teams to move away from conventional manual and out-of-date processes. The e-CRF+® xCTMS provides end-to-end oversight of trial activities to help study teams make decisions based on latest information. When united with e-CRF+® 3Q XaaS platform, it offers a turn-key solution to manage study milestones, sites, monitoring, eTMF, while accelerating timelines. The second product, e-CRF+® xEDC software, is built upon the site digital healthcare systems. It offers sponsors and CROs a new and cost-effective way to capture, manage, and report clinical data. “It is simple to use and the built-in AI algorithm assures data high quality and best compliance,” says Mr. Lu. When unified with e-CRF+® 3Q XaaS platform, it offers a turn-key solution to clinical data capture, SDV, and reporting.

Next in line is ECRFPlus’s e-CRF+® GEI product, which is a site ERP system specifically designed for sites to manage study projects, timelines, eTMF, clinical process, and study quality (GCP). This software consists of easy-to-use local IRB management, payment and study drug management, etc. Additionally, ECRFPlus also offers a site clinical trial management system, e-CRF+® sCTMS—specifically designed for sites to manage study lifecycle activities including subject screening, consenting, dosing, procedures, eTMF, and regulatory compliances. This software empowers sponsors, CROs to conduct digital trials, providing a new way for clinical acceleration. Lastly, ECRFPlus also offers a site clinical data capture and management system, e-CRF+® sEDC, that has been designed for sites to conduct digital trials of Phase I-IV, IIT, and real world studies. Its seamless integration with site healthcare systems automates eCRF data capture and SDV, improving study efficiency and data quality.

Through the portfolio of products, ECRFPlus is offering a turn-key end-to-end digital trial solution for global pharma and CROs, and leading them to the adoption of next-generation eClinical solutions and end-to-end XaaS services. “We partner with sponsors, CROs, SMOs to deliver the end-to-end digital trial solution and RWS solution that are based on our 3Q eClinical framework,” concludes Mr. Lu.